$CRMD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CorMedix Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CorMedix Inc.. Get notifications about new insider transactions in CorMedix Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 13 2021 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | A | 8.32 | 30,000 | 249,600 | 30,000 | ||
Jan 13 2021 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | A | 8.32 | 30,000 | 249,600 | 30,000 | ||
Jan 13 2021 | CRMD | CorMedix Inc. | Duncan Gregory Scott | Option Exercise | A | 8.32 | 20,000 | 166,400 | 20,000 | ||
Jan 13 2021 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 8.32 | 30,000 | 249,600 | 30,000 | ||
Jan 13 2021 | CRMD | CorMedix Inc. | Costa Paulo F | Option Exercise | A | 8.32 | 20,000 | 166,400 | 20,000 | ||
Jan 13 2021 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Option Exercise | A | 8.32 | 320,000 | 2,662,400 | 320,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Option Exercise | A | 8.32 | 140,000 | 1,164,800 | 140,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | David Matthew T | Chief Financial Off ... | Option Exercise | A | 8.32 | 80,000 | 665,600 | 80,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 8.32 | 140,000 | 1,164,800 | 140,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | Masson-Hurlburt Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 8.32 | 140,000 | 1,164,800 | 140,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | DUNTON ALAN W | Option Exercise | A | 8.32 | 30,000 | 249,600 | 30,000 | ||
Jan 13 2021 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 8.32 | 140,000 | 1,164,800 | 140,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | Masson-Hurlburt Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 8.32 | 140,000 | 1,164,800 | 140,000 | |
Jan 13 2021 | CRMD | CorMedix Inc. | DUNTON ALAN W | Option Exercise | A | 8.32 | 30,000 | 249,600 | 30,000 | ||
Nov 18 2020 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 3,583 | 0 | 3,583 | ||
Nov 04 2020 | CRMD | CorMedix Inc. | Duncan Gregory Scott | Option Exercise | A | 5.00 | 2,500 | 12,500 | 2,500 | ||
Nov 04 2020 | CRMD | CorMedix Inc. | Duncan Gregory Scott | Option Exercise | A | 5.00 | 20,000 | 100,000 | 20,000 | ||
Sep 17 2020 | CRMD | CorMedix Inc. | Costa Paulo F | Option Exercise | A | 4.57 | 3,750 | 17,138 | 3,750 | ||
Sep 17 2020 | CRMD | CorMedix Inc. | Costa Paulo F | Option Exercise | A | 4.57 | 20,000 | 91,400 | 20,000 | ||
Sep 09 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | P | 3.98 | 2,215 | 8,816 | 60,498 | 58.3 K to 60.5 K (+3.80 %) | |
Sep 09 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | P | 4.00 | 3,500 | 14,000 | 58,283 | 54.8 K to 58.3 K (+6.39 %) | |
Sep 08 2020 | CRMD | CorMedix Inc. | David Matthew T | Chief Financial Off ... | Buy | P | 4.07 | 1,150 | 4,681 | 1,150 | 0 to 1.2 K |
Sep 04 2020 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 4.27 | 15,300 | 65,359 | 150,034 | 134.7 K to 150 K (+11.36 %) | |
Aug 20 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 4.90 | 8,433 | 41,296 | 178,767 | 170.3 K to 178.8 K (+4.95 %) | |
Aug 20 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 4.91 | 9,404 | 46,176 | 170,334 | 160.9 K to 170.3 K (+5.84 %) | |
Aug 20 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 4.86 | 21,082 | 102,366 | 160,930 | 139.8 K to 160.9 K (+15.07 %) | |
Aug 20 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 4.62 | 4,500 | 20,790 | 139,848 | 135.3 K to 139.8 K (+3.32 %) | |
Aug 20 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 4.60 | 2,331 | 10,723 | 135,348 | 133 K to 135.3 K (+1.75 %) | |
Aug 17 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | P | 4.35 | 10,000 | 43,460 | 96,878 | 86.9 K to 96.9 K (+11.51 %) |
Aug 17 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | P | 4.14 | 7,500 | 31,050 | 86,878 | 79.4 K to 86.9 K (+9.45 %) |
Aug 17 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | P | 4.16 | 10,000 | 41,600 | 79,378 | 69.4 K to 79.4 K (+14.41 %) |
Aug 17 2020 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 4,770 | 0 | 4,770 | ||
Aug 17 2020 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Buy | P | 4.03 | 2,525 | 10,176 | 7,200 | 4.7 K to 7.2 K (+54.01 %) |
Aug 17 2020 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 4.08 | 15,000 | 61,160 | 134,734 | 119.7 K to 134.7 K (+12.53 %) | |
Aug 17 2020 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Buy | P | 4.14 | 4,830 | 19,985 | 60,905 | 56.1 K to 60.9 K (+8.61 %) |
Aug 14 2020 | CRMD | CorMedix Inc. | DUNTON ALAN W | Buy | P | 3.95 | 5,000 | 19,750 | 6,250 | 1.3 K to 6.3 K (+400.00 %) | |
May 18 2020 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 5,253 | 0 | 5,253 | ||
May 18 2020 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 3.85 | 10,000 | 38,500 | 119,734 | 109.7 K to 119.7 K (+9.11 %) | |
May 13 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 4.08 | 37,500 | 153,000 | 37,500 | |
May 13 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 4.08 | 37,500 | 153,000 | 37,500 | |
May 13 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 5.63 | 37,500 | 211,125 | 37,500 | |
May 13 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 5.63 | 37,500 | 211,125 | 37,500 | |
May 13 2020 | CRMD | CorMedix Inc. | Masson-Hurlburt Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 4.08 | 37,500 | 153,000 | 37,500 | |
May 13 2020 | CRMD | CorMedix Inc. | Masson-Hurlburt Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 5.63 | 37,500 | 211,125 | 37,500 | |
May 13 2020 | CRMD | CorMedix Inc. | David Matthew T | EVP, Chief Financia ... | Option Exercise | A | 4.08 | 125,000 | 510,000 | 125,000 | |
May 13 2020 | CRMD | CorMedix Inc. | David Matthew T | EVP, Chief Financia ... | Option Exercise | A | 5.63 | 125,000 | 703,750 | 125,000 | |
Mar 19 2020 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Buy | P | 3.05 | 3,250 | 9,913 | 4,675 | 1.4 K to 4.7 K (+228.07 %) |
Mar 18 2020 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Buy | P | 2.61 | 3,500 | 9,135 | 56,075 | 52.6 K to 56.1 K (+6.66 %) |
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | X | 4.50 | 3,000 | 13,500 | 3,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | X | 4.50 | 3,000 | 13,500 | 3,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | X | 4.50 | 4,500 | 20,250 | 4,500 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | X | 4.50 | 4,500 | 20,250 | 4,500 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | X | 4.50 | 3,000 | 13,500 | 30,152 | 27.2 K to 30.2 K (+11.05 %) | |
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | X | 4.50 | 3,000 | 13,500 | 30,152 | 27.2 K to 30.2 K (+11.05 %) | |
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | X | 4.50 | 4,500 | 20,250 | 59,776 | 55.3 K to 59.8 K (+8.14 %) | |
Feb 27 2020 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | X | 4.50 | 4,500 | 20,250 | 59,776 | 55.3 K to 59.8 K (+8.14 %) | |
Feb 27 2020 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Khan Mehmood | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Option Exercise | A | 5.63 | 24,764 | 139,421 | 24,764 | |
Feb 27 2020 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Option Exercise | A | 5.63 | 24,764 | 139,421 | 24,764 | |
Feb 27 2020 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Option Exercise | A | 5.63 | 100,630 | 566,547 | 100,630 | |
Feb 27 2020 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Option Exercise | A | 5.63 | 100,630 | 566,547 | 100,630 | |
Feb 27 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 5.63 | 24,764 | 139,421 | 24,764 | |
Feb 27 2020 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 5.63 | 24,764 | 139,421 | 24,764 | |
Feb 27 2020 | CRMD | CorMedix Inc. | Masson Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 5.63 | 24,764 | 139,421 | 24,764 | |
Feb 27 2020 | CRMD | CorMedix Inc. | Masson Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 5.63 | 24,764 | 139,421 | 24,764 | |
Feb 27 2020 | CRMD | CorMedix Inc. | DUNTON ALAN W | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 27 2020 | CRMD | CorMedix Inc. | DUNTON ALAN W | Option Exercise | A | 5.63 | 15,000 | 84,450 | 15,000 | ||
Feb 19 2020 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 1,706 | 0 | 1,706 | ||
Jan 02 2020 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Buy | P | 7.04 | 1,425 | 10,038 | 1,425 | 0 to 1.4 K |
Dec 17 2019 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 6.58 | 17,000 | 111,925 | 133,017 | 116 K to 133 K (+14.65 %) | |
Nov 18 2019 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 2,099 | 0 | 2,099 | ||
Oct 01 2019 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | P | 6.75 | 5,000 | 33,750 | 55,276 | 50.3 K to 55.3 K (+9.95 %) | |
Oct 01 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 6.81 | 5,000 | 34,050 | 109,734 | 104.7 K to 109.7 K (+4.77 %) | |
Oct 01 2019 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 6.88 | 1,000 | 6,879 | 27,517 | 26.5 K to 27.5 K (+3.77 %) |
Sep 30 2019 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Option Exercise | A | 6.82 | 120,000 | 818,400 | 120,000 | |
Aug 19 2019 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 8.18 | 1,000 | 8,180 | 26,517 | 25.5 K to 26.5 K (+3.92 %) |
Aug 19 2019 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 8.18 | 1,000 | 8,180 | 26,517 | 25.5 K to 26.5 K (+3.92 %) |
Aug 16 2019 | CRMD | CorMedix Inc. | Dillione Janet | Director | Option Exercise | A | 0.00 | 945 | 0 | 945 | |
Aug 16 2019 | CRMD | CorMedix Inc. | Dillione Janet | Director | Buy | P | 8.19 | 6,147 | 50,344 | 53,473 | 47.3 K to 53.5 K (+12.99 %) |
Aug 16 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Director | Buy | P | 8.06 | 6,000 | 48,360 | 104,734 | 98.7 K to 104.7 K (+6.08 %) |
Jul 16 2019 | CRMD | CorMedix Inc. | DUNTON ALAN W | Option Exercise | A | 8.95 | 7,500 | 67,125 | 7,500 | ||
Jul 16 2019 | CRMD | CorMedix Inc. | DUNTON ALAN W | Grant | A | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K | |
May 24 2019 | CRMD | CorMedix Inc. | Mounts Phoebe | General Counsel | Option Exercise | A | 7.92 | 70,000 | 554,400 | 70,000 | |
May 17 2019 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 1,126 | 0 | 226 | ||
May 17 2019 | CRMD | CorMedix Inc. | Dillione Janet | Buy | P | 6.74 | 11,144 | 75,111 | 47,326 | 36.2 K to 47.3 K (+30.80 %) | |
Apr 01 2019 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 9.35 | 100 | 935 | 25,517 | 25.4 K to 25.5 K (+0.39 %) |
Apr 01 2019 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 9.35 | 100 | 935 | 25,517 | 25.4 K to 25.5 K (+0.39 %) |
Mar 27 2019 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Buy | P | 7.55 | 2,500 | 18,875 | 52,575 | 50.1 K to 52.6 K (+4.99 %) |
Mar 27 2019 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | P | 7.73 | 5,000 | 38,650 | 69,378 | 64.4 K to 69.4 K (+7.77 %) |
Mar 25 2019 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | P | 1.69 | 15,000 | 25,350 | 321,890 | 306.9 K to 321.9 K (+4.89 %) |
Mar 22 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 1.65 | 20,000 | 33,000 | 493,666 | 473.7 K to 493.7 K (+4.22 %) | |
Mar 20 2019 | CRMD | CorMedix Inc. | Dillione Janet | Buy | P | 1.67 | 42,000 | 69,972 | 180,909 | 138.9 K to 180.9 K (+30.24 %) | |
Mar 04 2019 | CRMD | CorMedix Inc. | DUNTON ALAN W | Option Exercise | A | 1.70 | 100,000 | 170,000 | 100,000 | ||
Feb 19 2019 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 4,213 | 0 | 4,213 | ||
Jan 11 2019 | CRMD | CorMedix Inc. | Masson Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 1.66 | 120,000 | 199,200 | 120,000 | |
Jan 11 2019 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Option Exercise | A | 1.66 | 400,000 | 664,000 | 400,000 | |
Jan 11 2019 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | A | 1.66 | 45,000 | 74,700 | 45,000 | |
Jan 11 2019 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Option Exercise | A | 1.66 | 100,000 | 166,000 | 100,000 | |
Jan 11 2019 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | A | 1.66 | 75,000 | 124,500 | 75,000 | ||
Jan 11 2019 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Grant | A | 0.00 | 10,000 | 0 | 251,379 | 241.4 K to 251.4 K (+4.14 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Grant | A | 0.00 | 7,500 | 0 | 241,379 | 233.9 K to 241.4 K (+3.21 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Grant | A | 0.00 | 12,500 | 0 | 233,879 | 221.4 K to 233.9 K (+5.65 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Khan Mehmood | Option Exercise | A | 1.66 | 75,000 | 124,500 | 75,000 | ||
Jan 11 2019 | CRMD | CorMedix Inc. | Khan Mehmood | Grant | A | 0.00 | 3,000 | 0 | 580,083 | 577.1 K to 580.1 K (+0.52 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Khan Mehmood | Grant | A | 0.00 | 12,500 | 0 | 577,083 | 564.6 K to 577.1 K (+2.21 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | A | 1.66 | 75,000 | 124,500 | 75,000 | ||
Jan 11 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Grant | A | 0.00 | 5,000 | 0 | 473,666 | 468.7 K to 473.7 K (+1.07 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Grant | A | 0.00 | 10,000 | 0 | 468,666 | 458.7 K to 468.7 K (+2.18 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Grant | A | 0.00 | 15,000 | 0 | 458,666 | 443.7 K to 458.7 K (+3.38 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Kaplan Myron | Grant | A | 0.00 | 12,500 | 0 | 443,666 | 431.2 K to 443.7 K (+2.90 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Gelbfish Gary A. | Option Exercise | A | 1.66 | 75,000 | 124,500 | 75,000 | ||
Jan 11 2019 | CRMD | CorMedix Inc. | Gelbfish Gary A. | Grant | A | 0.00 | 12,500 | 0 | 2,654,871 | 2.6 M to 2.7 M (+0.47 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 1.66 | 75,000 | 124,500 | 75,000 | ||
Jan 11 2019 | CRMD | CorMedix Inc. | Dillione Janet | Grant | A | 0.00 | 5,000 | 0 | 138,909 | 133.9 K to 138.9 K (+3.73 %) | |
Jan 11 2019 | CRMD | CorMedix Inc. | Dillione Janet | Grant | A | 0.00 | 12,500 | 0 | 133,909 | 121.4 K to 133.9 K (+10.30 %) | |
Jan 03 2019 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | M | 0.00 | 18,029 | 0 | 0 | |
Jan 03 2019 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | M | 0.00 | 18,029 | 0 | 306,890 | 288.9 K to 306.9 K (+6.24 %) |
Dec 21 2018 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Buy | P | 1.18 | 20,000 | 23,500 | 135,757 | 115.8 K to 135.8 K (+17.28 %) | |
Dec 21 2018 | CRMD | CorMedix Inc. | Khan Mehmood | Buy | P | 1.24 | 100,000 | 124,410 | 564,583 | 464.6 K to 564.6 K (+21.52 %) | |
Dec 17 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 1.47 | 50,000 | 73,300 | 431,166 | 381.2 K to 431.2 K (+13.12 %) | |
Dec 06 2018 | CRMD | CorMedix Inc. | Masson Elizabeth | EVP, Head of Clinic ... | Option Exercise | M | 0.29 | 40,000 | 11,600 | 270,000 | |
Dec 06 2018 | CRMD | CorMedix Inc. | Masson Elizabeth | EVP, Head of Clinic ... | Buy | M | 0.29 | 40,000 | 11,600 | 40,000 | 0 to 40 K |
Nov 30 2018 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Buy | P | 1.45 | 250,000 | 363,150 | 288,861 | 38.9 K to 288.9 K (+643.32 %) |
Nov 27 2018 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Buy | P | 1.28 | 3,500 | 4,480 | 228,873 | 225.4 K to 228.9 K (+1.55 %) |
Nov 27 2018 | CRMD | CorMedix Inc. | Baluch Khoso | Chief Executive Off ... | Buy | P | 1.21 | 21,500 | 26,015 | 250,373 | 228.9 K to 250.4 K (+9.39 %) |
Nov 27 2018 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 1.17 | 25,000 | 29,213 | 127,083 | 102.1 K to 127.1 K (+24.49 %) |
Nov 27 2018 | CRMD | CorMedix Inc. | Cook Robert W. | Chief Financial Off ... | Buy | P | 1.17 | 25,000 | 29,213 | 127,083 | 102.1 K to 127.1 K (+24.49 %) |
Nov 27 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | P | 1.30 | 50,000 | 64,795 | 371,166 | 321.2 K to 371.2 K (+15.57 %) | |
Nov 27 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
Nov 27 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | M | 0.00 | 5,000 | 0 | 321,166 | 316.2 K to 321.2 K (+1.58 %) | |
Nov 16 2018 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 6,637 | 0 | 6,637 | ||
Oct 16 2018 | CRMD | CorMedix Inc. | Gelbfish Gary A. | Option Exercise | J | 0.75 | 1,000,000 | 750,000 | 0 | ||
Oct 16 2018 | CRMD | CorMedix Inc. | Gelbfish Gary A. | Option Exercise | M | 1.05 | 1,000,000 | 1,050,000 | 0 | ||
Oct 16 2018 | CRMD | CorMedix Inc. | Gelbfish Gary A. | Payment of Exercise | F | 2.24 | 468,750 | 1,050,000 | 2,632,371 | 3.1 M to 2.6 M (-15.12 %) | |
Oct 16 2018 | CRMD | CorMedix Inc. | Gelbfish Gary A. | Buy | M | 1.05 | 1,000,000 | 1,050,000 | 3,101,121 | 2.1 M to 3.1 M (+47.59 %) | |
Oct 01 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | ||
Oct 01 2018 | CRMD | CorMedix Inc. | Lefkowitz Steven W | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | ||
Aug 16 2018 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 13,636 | 0 | 13,636 | ||
May 17 2018 | CRMD | CorMedix Inc. | Dillione Janet | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | ||
Apr 09 2018 | CRMD | CorMedix Inc. | Masson Elizabeth | EVP, Head of Clinic ... | Option Exercise | A | 0.29 | 310,000 | 89,900 | 310,000 | |
Mar 22 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | ||
Mar 22 2018 | CRMD | CorMedix Inc. | Kaplan Myron | Buy | M | 0.00 | 10,000 | 0 | 294,166 | 284.2 K to 294.2 K (+3.52 %) | |
Mar 22 2018 | CRMD | CorMedix Inc. | ARMSTRONG JR. JOHN L. | Exec VP of Tech Ope ... | Option Exercise | M | 0.00 | 18,028 | 0 | 18,029 |